ALEXANDRIA, Va., July 16 -- United States Patent no. 12,358,997, issued on July 15, was assigned to HOFFMANN-LA ROCHE INC. (Little Falls, N.J.).
"Bispecific anti-human A-beta/anti-human transferrin receptor antibodies" was invented by Harald Duerr (Starnberg, Germany), Sebastian Fenn (Achmuehle/Eurasburg, Germany), Ulrich Goepfert (Penzberg, Germany), Sabine Imhof-Jung (Planegg, Germany), Christian Klein (Bonstetten, Switzerland), Laurent Lariviere (Munich), Michael Molhoj (Munich), Joerg Thomas Regula (Munich), Petra Rueger (Penzberg, Germany) and Wolfgang Schaefer (Mannheim, Germany).
According to the abstract* released by the U.S. Patent & Trademark Office: "Herein are provided bispecific anti-human A-beta/human transferrin receptor an...